3 Best Stocks to Buy Now, 5/30/2024, According to Top Analysts 
Market News

3 Best Stocks to Buy Now, 5/30/2024, According to Top Analysts 

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Cigna (NYSE:CI) – Cigna is an insurance and health services provider. Today, J.P. Morgan analyst Lisa Gill reiterated a Buy rating on the stock with a price target of $435. In the last three months, 11 out of the 12 Top Analysts covering the stock have rated it a Buy. Altogether, their 12-month price targets imply an upside of about 20%.

Grab (NASDAQ:GRAB) – Grab is a technology company that offers ride-hailing, food delivery, and digital payment services. Today, DBS analyst Sachin Mittal reiterated a Buy rating on the stock with a price target of $4.50. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of over 27%.

Braze (NASDAQ:BRZE) – Braze is a cloud-based software company. Today, J.P. Morgan analyst Pinjalim Bora maintained a Buy rating on the stock. In the last three months, all nine Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of more than 59%.

Who are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
TheFlyCigna cutting Medicare Advantage plans in several states, Modern Healthcare says
Annika MasraniCigna Takes Legal Action Against FTC Over Drug-Price Report
TheFlyCigna price target raised to $422 from $402 at Jefferies
Go Ad-Free with Our App